CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company
NextCure, Inc.
Sign in to watch- Ticker
- NXTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475231247
- Phone
- 240-399-4900
- Business address
- 2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
- 8-K Event Other events
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 424B1 Offering Prospectus
- D Other Notice of Sales of Unregistered Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 3/A Insider 3/A
- 8-K Event Executive or director change
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- 424B2 Offering Prospectus
Page 4 of 20 · 400 filings